DOYLESTOWN, Pa., Feb. 05, 2019 (GLOBE NEWSWIRE) — Kannalife, Inc. (“Kannalife”) (OTC: KLFE), a bio-pharmaceutical and phyto-medical company, is pleased to announce and congratulate the Company’s spokesperson – former NFL and Kansas City Chiefs Hall of Famer – Nick Lowery […]
Doylestown, PA – January 16, 2019 – Kannalife, Inc. (“Kannalife”) (OTC: KLFE), a bio-pharmaceutical and phyto-medical company, is pleased to announce that the Company’s name change from TYG Solutions Corp. to Kannalife, Inc. and the change of ticker symbol to “KLFE” has been reviewed and processed by […]
Gene Collier: How Mike Webster memories still motivate ex-Chief Nick Lowery by Gene Collier, Pittsburg Post-Gazette https://www.post-gazette.com/sports/gene-collier/2018/12/09/mike-webster-steelers-nfl-concussion-cte-nick-lowery-chiefs/stories/201812090074 With four weeks remaining in yet another imponderable NFL season, it’s impossible to say whether the Steelers or the Baltimore Ravens will win […]
Nick Lowery, former Kansas City Chiefs Kicker and Kannalife Spokesperson, visits CNBC’s Power Hour as he holds first place in this years Stock Draft.
FULL ARTICLE HERE: https://www.biospace.com/article/cannabis-based-drug-developers-are-hopeful-as-fda-approves-first-marijuana-based-seizure-treatment/ Cannabis-Based Drug Developers Are Hopeful as FDA Approves First Marijuana-based Seizure Treatment – By Alex Keown In a first of its kind ruling, the U.S. Food and Drug Administration (FDA) approved GW Pharmaceuticals’ Epidiolex, a cannabis-based […]
Kannalife scientist Dr. Doug Brenneman and CEO Dean Petkanas were interviewed by journalist Harry Smith on Dateline NBC Special “Growing Promise” which aired on Sunday May 20, 2018. The topics discussed were cannabidiol (cbd), the 507 Patent (#6630507) “Cannabinoids as […]
Former NFL players Nick Lowery and Eric Dickerson on CNBC. First-time Stock Draft investors on their investment strategy from CNBC.
10-30-17 Kannalife spokesman, Chiefs Hall of Famer Nick Lowery joins Kevin in studio to chat about kicking and Hall of Fame and Alumni weekend.
Doylestown, PA – Sept. 22, 2017 / Kannalife Sciences, Inc., a pharmaceutical and phyto-medical company, announced today that former three time NFL Pro-Bowl and Kansas City Chiefs placekicker, Nick Lowery, has joined Kannalife corporate advisory board to lead the Company’s initiative on […]
Last week the U.S. Drug Enforcement Administration (“DEA”) made an unexpected ruling regarding the ongoing scheduling of cannabis (aka: marijuana). After much deliberation, almost a full year in the waiting, the DEA announced that there will be no change to […]
How cannabis is helping one company research treatment of CTE by Ben Baskin – Read full article here: http://www.si.com/nfl/2016/07/12/cannabis-cte-treatment-kannalife Imagine if you said to Paul Tagliabue, back in 2003, that Ricky Williams might one day be able to save Junior Seau’s […]
ARTICLE LINK: http://www.pharmtech.com/us-regulators-permit-kannalife-sciences-import-cannabidiol-feasibility-studies The US Drug Enforcement Agency (DEA) has granted permission for the import of pharmaceutical-grade cannabidiol to Catalent Pharma Solutions for a feasibility study in conjunction with Kannalife Sciences, according to a company press release. Upon completion of […]
“CTE is the NFL’s industrial disease … Unless the NFL makes a serious shift, it’s very difficult to believe that it will continue to be the most popular sports league in America.” Former lineman Marvin Washington on why the future […]
Dr. Sanjay Gupta interviews Kannalife Sciences CEO Dean Petkanas and the exclusive license to the US Government’s patent on Cannabis. “Cannabinoids as Antioxidants and Neuroprotectants”. Kannalife is working on two (2) distinct disease indications that effect the Brain. One is […]
Next Page »
June 27, 2019 at 9:00 am
May 21, 2019 at 9:00 pm
March 24, 2019 at 7:44 pm
February 5, 2019 at 9:00 am